Literature DB >> 18369309

"Pagetoid" eccrine carcinoma of the vulva: report of an unusual case with review of the literature.

Andrea Grin1, Terrence Colgan, Stephane Laframboise, Patricia Shaw, Danny Ghazarian.   

Abstract

Sweat gland carcinoma of the vulva is rare and may be classified as being of eccrine, apocrine, or mixed origin. Most reported cases of vulvar sweat gland carcinomas associated with extramammary Paget disease describe a tumor of apocrine origin. We report a case of a vulvar sweat gland carcinoma of eccrine origin associated with Pagetoid extension. A review of the literature and the differential diagnosis are also presented. To our knowledge, this is the second case of vulvar sweat gland carcinoma of eccrine origin associated with extramammary Paget disease.

Entities:  

Mesh:

Year:  2008        PMID: 18369309     DOI: 10.1097/LGT.0b013e31815b2156

Source DB:  PubMed          Journal:  J Low Genit Tract Dis        ISSN: 1089-2591            Impact factor:   1.925


  4 in total

Review 1.  Effects of imiquimod on vulvar Paget's disease: a systematic review of literature.

Authors:  Hiroko Machida; Aida Moeini; Lynda D Roman; Koji Matsuo
Journal:  Gynecol Oncol       Date:  2015-07-17       Impact factor: 5.482

2.  ER/PR positive epidermotropic primary cutaneous eccrine carcinoma as a cutaneous manifestation of MEN 2B.

Authors:  Phyu P Aung; Leomar Y Ballester; Zied Abdullaev; Svetlana D Pack; Deborah L Cummins; Meera Mahalingam
Journal:  J Am Acad Dermatol       Date:  2013-12       Impact factor: 11.527

3.  Apocrine adenocarcinoma of the vulva.

Authors:  Babita Kajal; Hetal Talati; Dean Daya; Salem Alowami
Journal:  Rare Tumors       Date:  2013-09-09

4.  GATA3 is a sensitive marker for primary genital extramammary paget disease: an immunohistochemical study of 72 cases with comparison to gross cystic disease fluid protein 15.

Authors:  Ming Zhao; Lixin Zhou; Li Sun; Yan Song; Yunquan Guo; Xun Zhang; Feng Zhao; Peng Wang; Junqiu Yue; Dongfeng Niu; Zhongwu Li; Xiaozheng Huang; Qiang Kang; Lin Jia; Jinping Lai; Dengfeng Cao
Journal:  Diagn Pathol       Date:  2017-07-10       Impact factor: 2.644

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.